Safety of topical corticosteroids in pregnancy (Review) [PDF]
, 2015 Background Topical corticosteroids are the most frequently prescribed dermatological treatment and are often used by pregnant women with skin conditions. However, little is known about their safety in pregnancy.
Altman +71 more
core +1 more source
Combined pathogenetic therapy of allergic dermatoses in children
Медицинский совет, 2021 Allergodermatoses make up the majority of allergic skin diseases in childhood, have a recurrent course and significantly disrupt the quality of life of patients and their families. The constant use of emollients, allowing to lengthen periods of remission
J. S. Kovaleva +3 more
doaj +1 more source
Фармацевтичний журнал, 2022 The prevalence of atopic dermatitis (AD) is growing rapidly among the population, treatment protocols need to be reviewed, taking into account evidence-based medicine data and the introduction of new drugs and new forms in the country's market.
O. M. Zaliska +3 more
doaj +1 more source
Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial. [PDF]
, 2015 BackgroundToxic epidermal necrolysis (TEN) is a rare systemic allergic drug eruption with high patient mortality. Currently, no established treatments have been shown to be effective for TEN beyond supportive care.
Kim, Kyoungmi +6 more
core +4 more sources
An experience of using methylprednisolone aceponate in the therapy of lupus erythematosus tumidus
Vestnik Dermatologii i Venerologii, 2017 Lupus erythematosus tumidus is a rare skin form of lupus erythematosus. About 250 cases of lupus erythematosus tumidus have been described in the world by now.
L. P. Kotrekhova, A. A. Vashkevich
doaj +1 more source
Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants [PDF]
, 2015 Atopic dermatitis (AD) is a distressing dermatological disease, which is highly prevalent during infancy, can persist into later life and requires long-term management with anti-inflammatory compounds.
Boguniewicz, Mark +25 more
core +6 more sources
Опыт применения 0,1% метилпреднизолона ацепоната в комплексной терапии стероидчувствительных дерматозов [PDF]
, 2016 The review describes the structure and pharmacokinetics of 0.1% methylprednisolone aceponate, world’s data practice, showing high efficiency and safety of this drug in the treatment of chronic dermatoses, presents the results of study the therapeutic ...
Karchova V.V., Kondratyeva Y.S.
core +2 more sources
Pediatrician’s view about the treatment of atopic dermatitis with methylprednisolone
Медицинский совет, 2019 The article considers the present-day idea of the etiopathogenesis of atopic dermatitis in children, which forms, from the pediatrician’s point of view, basis for decision making on effective modern therapeutic and preventive measures.
F. P. Romanyuk
doaj +1 more source
Anti-inflammatory effects of methylprednisolone aceponate in animals.
Folia Pharmacologica Japonica, 1991 In the case of dermal application of the drugs to croton oil-induced ear edema in rats and picryl chloride-induced delayed type hypersensitivity in mice, the anti-inflammatory effect of methylprednisolone aceponate (MPA) was slightly weaker than those of clobetasol 17-propionate and diflucortolone 21-valerate, but stronger than those of hydrocortisone ...
Y, Ikoma +3 more
openaire +3 more sources
Development and Validation of HPLC method for determination of Methylprednisolone aceponate in cream
Macedonian Pharmaceutical Bulletin, 2022 The validation results show that the method is accurate, precise, robust, selective, and linear in the given range. It is easily applicable because it does not require complex sample preparation, or special preparation of the working environment.
Apostolova, Paulina +5 more
openaire +4 more sources